Inherited and congenital predisposition to hematologic malignancies: reports from the 56th American Society of Hematology annual meeting
Chen Xue;,Liu Hongxing;

..............page:65-70

Progress of chimeric antigen receptor T cell immunotherapy in B cell hematologic malignancies:reports from the 56th American Society of Hematology annual meeting
Deng Biping;,Liu Hongxing;,Tong Chunrong;

..............page:71-73,78

Progression of molecular genetics in Ph-like acute lymphoblastic leukemia: reports from the 56th American Society of Hematology annual meeting
Zhang Yang;,Liu Hongxing;

..............page:74-78

Epigenetic targeting approaches for acute myeloid leukemia: reports form the 56th American Society of Hematology annual meeting
Zhang Danfeng;,Pan Ling;

..............page:79-84,87

Progress of guidelines for quantifying iron overload: reports from the 56th American Society of Hematology annual meeting
Tang Xudong;,Zhang Lu;,Liu Feng;

..............page:85-87

Progress of guidelines for established and novel agents for myelodysplastic syndromes: reports form the 56th American Society of Hematology annual meeting
Tang Xudong;,Zhang Lu;,Liu Feng;

..............page:88-90,100

Familial hemophagocytic lymphohistiocytosis associated gene mutations in Chinese lymphoma patients with human herpes virus infection
chen xue ;, zhang yang ;, wang fang ;, zuo wen ;, wang mang jie ;, jin fang yuan ;, guo lei ;, wang ming yu ;, tong chun rong ;

..............page:91-95

Preliminary study of role of post-transcription regulation on SH2 domain-containing inositol 5'-phosphatase 1 gene expression by miR-155 in the pathogenesis of acute myeloid leukemia
Xue Hua;,Zhao Songying;,Wang Jing;,Fan Lixia;,Hua Luoming;,Luo Jianmin;

..............page:96-100

Primary lymphoma of bone: 9 cases reports and a clinical analysis of diagnosis and treatment
Pei Ruijun;,Wei Na;,Wang Yini;,Tang Ran;,Li Shuo;,Wang Zhao;

..............page:101-104,110

Analysis on prognostic factors of acute myeloid leukemia
Zhang Lulu;,Xia Hailong;

..............page:105-110

Clinical significance of indoleamine 2,3-dioxygenase expression in human acute leukemia
Chen Xiangli;,Guo Jianmin;,Zhang Yin;,Niu Xiaona;,Pei Xiaohang;,Zhang Wenhui;

..............page:111-114

Application of quantitative of preferentially expressed antigen of melanoma gene expression in monitoring acute myeloid leukemia and minimal residual disease
Hu Shufen;,Tan Dongmei;,Xie Weicheng;,Pang Ting;,Liu Zhiwei;,Wu Puzhao;

..............page:115-117

er tong ji xing b lin ba xi bao bai xue bing tel-aml1 ji yin biao da yu yu hou de guan xi
huang hui ;, yang wen ping ;, lin zuo zuo ;, xiong feng ;, liu zhi qiang ;, liang chang da ;, zhang xiao zhen ;

..............page:118-119

nei ke zhi liao qi xue zao xue gan xi bao yi zhi hou chang chuan kong yi li bing wen xian fu xi
qiang ping ;, tang bao lin ;, geng liang quan ;, liu hui lan ;, zhu xiao yu ;, zheng chang cheng ;, zhu zuo bo ;, liu xin ;, sun zi min ;

..............page:120-121

Prognostic effects of novel agents on cytogenetic abnormalities of multiple myeloma
Xiong Wenjie;

..............page:122-125

Research progress of novel tyrosine kinase inhibitor AC220 in the treatment of acute myeloid leukemia
Ge Li;

..............page:125-128

zhong hua yi xue hui bai xue bing lin ba liu za zhi gao yue

..............page:前插1-前插2